SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | SOLENO THERAPEUTICS INC | 3,068,031 | 9.9% | EDGAR |
SC 13G/A | 2024-02-14 | COMMODORE CAPITAL LP | SOLENO THERAPEUTICS INC | 700,000 | 2.3% | EDGAR |
SC 13G/A | 2024-02-13 | JANUS HENDERSON GROUP PLC | SOLENO THERAPEUTICS INC | 2,523,897 | 8.3% | EDGAR |
SC 13G/A | 2024-02-07 | ADAGE CAPITAL PARTNERS GP, L.L.C. | SOLENO THERAPEUTICS INC | 1,826,814 | 6.0% | EDGAR |
SC 13D/A | 2023-10-23 | PERCEPTIVE ADVISORS LLC | SOLENO THERAPEUTICS INC | 3,074,542 | 10.1% | EDGAR |
SC 13D/A | 2023-10-16 | Carlyle Group Inc. | SOLENO THERAPEUTICS INC | 2,893,615 | 10.0% | EDGAR |
SC 13G | 2023-10-12 | ADAGE CAPITAL PARTNERS GP, L.L.C. | SOLENO THERAPEUTICS INC | 1,327,000 | 8.7% | EDGAR |
SC 13G | 2023-10-12 | COMMODORE CAPITAL LP | SOLENO THERAPEUTICS INC | 885,741 | 6.0% | EDGAR |
SC 13D/A | 2023-10-11 | Vivo Opportunity Fund Holdings, L.P. | SOLENO THERAPEUTICS INC | 8,418,093 | 30.5% | EDGAR |
SC 13G | 2023-10-10 | Fairmount Funds Management LLC | SOLENO THERAPEUTICS INC | 950,000 | 6.2% | EDGAR |
SC 13G | 2023-10-06 | JANUS HENDERSON GROUP PLC | SOLENO THERAPEUTICS INC | 1,459,700 | 10.1% | EDGAR |
SC 13G | 2023-10-05 | RA CAPITAL MANAGEMENT, L.P. | SOLENO THERAPEUTICS INC | 1,233,300 | 4.6% | EDGAR |
SC 13D/A | 2023-10-03 | Carlyle Group Inc. | SOLENO THERAPEUTICS INC | 1,567,247 | 10.0% | EDGAR |
SC 13D/A | 2023-09-29 | PERCEPTIVE ADVISORS LLC | SOLENO THERAPEUTICS INC | 3,074,542 | 23.7% | EDGAR |
SC 13G/A | 2023-08-30 | HIRSCHMAN ORIN | SOLENO THERAPEUTICS INC | 498,610 | 4.9% | EDGAR |
SC 13D/A | 2023-08-18 | Carlyle Group Inc. | SOLENO THERAPEUTICS INC | 1,227,317 | 12.3% | EDGAR |
SC 13D/A | 2023-08-15 | PERCEPTIVE ADVISORS LLC | SOLENO THERAPEUTICS INC | 2,207,753 | 22.1% | EDGAR |
SC 13D/A | 2023-06-06 | PERCEPTIVE ADVISORS LLC | SOLENO THERAPEUTICS INC | 2,207,753 | 27.0% | EDGAR |
SC 13D | 2023-06-01 | Vivo Opportunity Fund Holdings, L.P. | SOLENO THERAPEUTICS INC | 8,418,093 | 50.8% | EDGAR |
SC 13D/A | 2023-05-30 | PERCEPTIVE ADVISORS LLC | SOLENO THERAPEUTICS INC | 2,029,455 | 24.8% | EDGAR |